Don't Routinely Recommend Praluent for High Cholesterol

Praluent (PRAL-you-ent, alirocumab) is the first "PCSK9 inhibitor" for high cholesterol.

It works by preventing PCSK9...proprotein convertase subtilisin kexin type 9...from binding and degrading liver LDL receptors. This leads to more LDL receptors...and more LDL cholesterol clearing from the blood.

Praluent can lower LDL by about 60%, regardless of statin use.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote